MagVenture TMS

Non-invasive, non-pharmaceutical, FDA cleared. TMS has been recommended by the American Psychiatric Association since 2010 for the treatment of major depressive disorder. TMS Therapy is free from common antidepressant drug side effects such as weight gain and sexual dysfunction. It is a non-invasive treatment, and does not require anesthesia. TMS is not to be confused with ECT (Electroconvulsive Therapy), and it does not affect cognitive function such as memory. Patients may resume daily activities right after treatment.

The MagVenture TMS Therapy procedure:

  • A session where the patient’s individual stimulation level (also known as motor threshold) is determined
  • 5 treatment sessions per week during a period of normally 4-6 weeks.
  • The duration of a standard TMS treatment session is between 19-37 minutes. In 2018, MagVenture also received FDA clearance for a newer, and much faster protcol called Express TMS. This procedure is similar to standard TMS but a session only lasts 3 minutes.
  • Maintenance treatment if needed.

Do you want to know more about what TMS Therapy is? Watch this short video about one patient’s journey with MagVenture TMS Therapy:

In Network With
Thrive
United Healhcare
Cigna
Aetna
Anthem - BlueCross
MHN - A Health Net Company
Magellan Health Insurances
Optum

   

Our practice has officially closed on Friday, January 20, 2023. It has been our privilege to have had the opportunity to meet the healthcare needs for individuals throughout the community.

In California, since the passage of SB-221 which went into effect starting July 2022, health plans and insurances are required to provide timely access to care including follow up appointments for primary care and specialist appointments as well as for other mental health follow-up appointments within 10-15 days. Information is also available at the following link: https://www.dmhc.ca.gov/healthcareincalifornia/yourhealthcarerights/timelyaccesstocare.aspx